Annual Operating Profit
-$34.33 M
+$47.03 M+57.81%
31 December 2023
Summary:
Kala Pharmaceuticals annual operaing income is currently -$34.33 million, with the most recent change of +$47.03 million (+57.81%) on 31 December 2023. During the last 3 years, it has risen by +$61.90 million (+64.33%). KALA annual operating profit is now -115.28% below its all-time high of -$15.95 million, reached on 31 December 2015.KALA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$7.62 M
+$1.03 M+11.93%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly operating income is currently -$7.62 million, with the most recent change of +$1.03 million (+11.93%) on 30 September 2024. Over the past year, it has dropped by -$86.00 thousand (-1.14%). KALA quarterly operating profit is now -50.16% below its all-time high of -$5.08 million, reached on 31 March 2016.KALA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$34.46 M
-$86.00 K-0.25%
30 September 2024
Summary:
Kala Pharmaceuticals TTM operating income is currently -$34.46 million, with the most recent change of -$86.00 thousand (-0.25%) on 30 September 2024. Over the past year, it has increased by +$1.54 million (+4.27%). KALA TTM operating profit is now -578.88% below its all-time high of -$5.08 million, reached on 31 March 2016.KALA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.8% | -1.1% | +4.3% |
| 3 y3 years | +64.3% | +70.8% | +69.3% |
| 5 y5 years | +47.0% | +64.7% | +62.4% |
KALA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +68.6% | -1.8% | +75.3% | -0.4% | +69.3% |
| 5 y | 5 years | at high | +68.6% | -1.8% | +75.3% | -0.4% | +69.3% |
| alltime | all time | -115.3% | +68.6% | -50.2% | +75.3% | -578.9% | +69.3% |
Kala Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.62 M(-11.9%) | -$34.46 M(+0.3%) |
| June 2024 | - | -$8.65 M(-19.1%) | -$34.37 M(-1.7%) |
| Mar 2024 | - | -$10.70 M(+42.9%) | -$34.96 M(+1.8%) |
| Dec 2023 | -$34.33 M(-57.8%) | -$7.49 M(-0.7%) | -$34.33 M(-4.6%) |
| Sept 2023 | - | -$7.54 M(-18.4%) | -$36.00 M(-16.3%) |
| June 2023 | - | -$9.24 M(-8.2%) | -$42.99 M(-29.0%) |
| Mar 2023 | - | -$10.07 M(+10.0%) | -$60.57 M(-25.5%) |
| Dec 2022 | -$81.36 M(-25.7%) | -$9.15 M(-37.0%) | -$81.36 M(-17.2%) |
| Sept 2022 | - | -$14.53 M(-45.8%) | -$98.20 M(-10.5%) |
| June 2022 | - | -$26.82 M(-13.1%) | -$109.75 M(-2.0%) |
| Mar 2022 | - | -$30.85 M(+18.6%) | -$111.97 M(+2.3%) |
| Dec 2021 | -$109.43 M(+13.7%) | -$26.00 M(-0.3%) | -$109.43 M(-2.7%) |
| Sept 2021 | - | -$26.07 M(-10.2%) | -$112.41 M(+0.2%) |
| June 2021 | - | -$29.05 M(+2.6%) | -$112.19 M(+7.4%) |
| Mar 2021 | - | -$28.31 M(-2.3%) | -$104.42 M(+8.5%) |
| Dec 2020 | -$96.23 M | -$28.98 M(+12.2%) | -$96.23 M(+10.0%) |
| Sept 2020 | - | -$25.84 M(+21.4%) | -$87.44 M(+5.1%) |
| June 2020 | - | -$21.28 M(+5.7%) | -$83.17 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$20.13 M(-0.4%) | -$84.30 M(-4.4%) |
| Dec 2019 | -$88.22 M(+36.3%) | -$20.20 M(-6.4%) | -$88.22 M(-3.7%) |
| Sept 2019 | - | -$21.57 M(-3.8%) | -$91.59 M(+7.1%) |
| June 2019 | - | -$22.41 M(-6.8%) | -$85.52 M(+10.2%) |
| Mar 2019 | - | -$24.05 M(+2.0%) | -$77.63 M(+19.9%) |
| Dec 2018 | -$64.72 M(+62.3%) | -$23.57 M(+52.1%) | -$64.72 M(+23.8%) |
| Sept 2018 | - | -$15.50 M(+6.7%) | -$52.29 M(+12.9%) |
| June 2018 | - | -$14.52 M(+30.3%) | -$46.33 M(+11.8%) |
| Mar 2018 | - | -$11.14 M(-0.0%) | -$41.44 M(+3.9%) |
| Dec 2017 | -$39.88 M(+22.1%) | -$11.14 M(+16.8%) | -$39.88 M(+3.0%) |
| Sept 2017 | - | -$9.53 M(-1.0%) | -$38.72 M(-0.5%) |
| June 2017 | - | -$9.63 M(+0.6%) | -$38.93 M(+4.8%) |
| Mar 2017 | - | -$9.57 M(-4.1%) | -$37.16 M(+13.8%) |
| Dec 2016 | -$32.67 M(+104.9%) | -$9.98 M(+2.4%) | -$32.67 M(+44.0%) |
| Sept 2016 | - | -$9.75 M(+24.0%) | -$22.68 M(+75.3%) |
| June 2016 | - | -$7.86 M(+54.9%) | -$12.94 M(+154.9%) |
| Mar 2016 | - | -$5.08 M | -$5.08 M |
| Dec 2015 | -$15.95 M | - | - |
FAQ
- What is Kala Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual operating profit year-on-year change?
- What is Kala Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly operating profit year-on-year change?
- What is Kala Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM operating profit year-on-year change?
What is Kala Pharmaceuticals annual operaing income?
The current annual operating profit of KALA is -$34.33 M
What is the all time high annual operating profit for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual operaing income is -$15.95 M
What is Kala Pharmaceuticals annual operating profit year-on-year change?
Over the past year, KALA annual operaing income has changed by +$47.03 M (+57.81%)
What is Kala Pharmaceuticals quarterly operating income?
The current quarterly operating profit of KALA is -$7.62 M
What is the all time high quarterly operating profit for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly operating income is -$5.08 M
What is Kala Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, KALA quarterly operating income has changed by -$86.00 K (-1.14%)
What is Kala Pharmaceuticals TTM operating income?
The current TTM operating profit of KALA is -$34.46 M
What is the all time high TTM operating profit for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM operating income is -$5.08 M
What is Kala Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, KALA TTM operating income has changed by +$1.54 M (+4.27%)